Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Ophthalmology Market Research

Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product (Anti-inflammatory Drugs, Artificial Tears, Punctal Plugs, Secretagogues), Therapy Area (Eye drops and Solutions, Gels and Ointments, Capsules and Tablets), Distribution Channel an

Best Price Guarantee Length Publisher Published Date SKU
from $3,950 121 Pages GlobalData November, 2022 GBDT17563165
Best Price Guarantee
Price from $3,950
Length 121 Pages
Publisher GlobalData
Published Date November, 2022
SKU GBDT17563165

Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product (Anti-inflammatory Drugs, Artificial Tears, Punctal Plugs, Secretagogues), Therapy Area (Eye drops and Solutions, Gels and Ointments, Capsules and Tablets), Distribution Channel and Segment Forecast, 2022-2027

Summary

The dry eye syndrome market size was valued at US$5,465.0 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.8% during 2022-2027. The dry eye syndrome market report provides an executive-level overview of dry eye syndrome worldwide today, with detailed forecasts of key indicators up to 2027.

This market intelligence report offers a thorough, forward-looking analysis of the global dry eye syndrome market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.

Key Highlights

The dry eye syndrome market size was valued at US$5,465.0 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.8% during 2022-2027. The major factors contributing to the market growth includes, rise in ageing population, growth in eye care centers to handle the rising burden of ophthalmological disorders, increasing research and development.

Scope

  • Overview of dry eye syndrome including industry trends, deals, and product & company profile
  • dry eye syndrome market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product, dosage form, distribution channel, and geographic segments.
  • Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the key product segments.
  • Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the dosage form segment. Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the distribution channel segment.
  • The competitive landscape: an examination of the positioning of leading players in dry eye syndrome market.
Reasons to Buy
  • This market intelligence report offers a thorough, forward-looking analysis of the dry eye syndrome market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData’s Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in dry eye syndrome markets.
  • The report also highlights key product, dosage form and distribution channel segments.
  • With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in dry eye syndrome market.


  • Executive Summary
    • Dry Eye Syndrome Market Snapshot
      • Table Fig.1 Market Snapshot ($Mn)
    • Dry Eye Syndrome Market- Key Findings
      • Table Fig.2 Key Segment Performance Snapshot
      • Table Key Trends, Drivers, and Challenges Overview
  • Market Landscape
    • Market Definition
      • RISK FACTORS AND COMORBIDITIES
        • Table Fig.3 Risk Factors and Comorbidities for DES
      • DISEASE CLASSIFICATION
        • Table Fig.4 Risk Factors and Comorbidities for DES
    • Market Scope and Segmentation
      • Table Research Scope and Segmentation
  • Disease Overview
    • Etiology and Pathophysiology
      • ETIOLOGY
        • Table Fig.5 Vicious Circle of Dry Eye Syndrome
      • PATHOPHYSIOLOGY
    • Epidemiological For Dry Eye Syndrome
      • AGE-SPECIFIC DIAGNOSED PREVALENT CASES OF DRY EYE SYNDROME
      • SEX-SPECIFIC DIAGNOSED PREVALENT CASES OF DRY EYE SYNDROME
      • DIAGNOSED PREVALENT CASES OF DRY EYE SYNDROME BY SEVERITY
      • TOTAL PREVALENT CASES OF DRY EYE SYNDROME
  • Disease Management
    • Diagnosis and Treatment Overview
      • DIAGNOSIS
        • Table Fig.6 Diagnostic Tests for Dry Eye Syndrome
      • TREATMENT GUIDELINES
        • Table Fig.7 Treatment Guidelines for Dry Eye Syndrome
      • CLINICAL PRACTICE
        • Table Fig.8 Country Profile - US
        • Table Fig.9 Country Profile - 5EU
        • Table Fig.10 Country Profile - Japan
        • Table Fig.11 Country Profile - India
  • Competitive Assessment
    • Cyclosporine
    • LFA-1 Antagonist
    • Mucin Secretagogue
    • Corticosteroids
    • Artificial Tears
    • Autologous Serum
  • Unmet Needs and Opportunity Assessment
    • Overview
      • Table Fig.12 Unmet Needs and Opportunities in Dry Eye Syndrome
    • More Treatment Options with Favorable Tolerability Profiles
    • Better Diagnostic Tools
    • Simplified Dosing with Cost-Effective Options
      • Table Fig.13 : Products in Clinical Development for Dry Eye Syndrome
  • Pipeline Assessment
    • Overview
    • Late-Stage Pipeline Products
      • Table Fig.14 : Key Phase IIb/III Trials for the Promising Pipeline Agents that GlobalData Expects be Licensed for Dry eye Syndrome in the Major Markets
      • Table Comparison of Therapeutic Classes in Development for DES
  • Dry Eye Syndrome Industry Analysis
    • Dry Eye Syndrome Market Structure - PORTER's Analysis
      • Table Fig.15 Global Dry Eye Syndrome PORTER's Five Force Analysis
    • Product Launches in Dry Eye Syndrome
      • Table Product Launches in Dry Eye Syndrome
    • Important Milestones in Dry Eye Syndrome
      • Table Important Milestones in Dry Eye Syndrome
  • Global Dry Eye Syndrome Revenue Opportunity
    • Global Dry Eye Syndrome Market
      • Table Fig.16 Global Dry Eye Syndrome Market - Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • Table Dry Eye Syndrome Market
  • Dry Eye Syndrome Product Outlook
    • Dry Eye Syndrome - Product Dive
      • Table Fig.17 Dry Eye Syndrome by Product - Market Overview ($Mn)
      • Table Fig.18 Dry Eye Syndrome by Product Share - 2021 & 2027 (%)
      • Table Dry Eye Syndrome by Product, 2020-2027 ($Mn)
      • ANTI-INFLAMMATORY DRUGS
        • Table Fig.19 Anti-inflammatory Drugs Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • ARTIFICIAL TEARS
        • Table Fig.20 Artificial Tears Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • PUNCTAL PLUGS
        • Table Fig.21 Punctal Plugs Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • SECRETAGOGUES
        • Table Fig.22 Secretagogues Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Dry Eye Syndrome Dosage Form Outlook
    • Dry Eye Syndrome -Dosage Form Dive
      • Table Fig.23 Dry Eye Syndrome by Dosage Form - Market Overview ($Mn)
      • Table Fig.24 Dry Eye Syndrome by Dosage Form Share - 2021 & 2027 (%)
      • Table Dry Eye Syndrome by Dosage Form, 2020-2027 ($Mn)
      • EYE DROPS AND SOLUTIONS
        • Table Fig.25 Eye Drops and Solutions Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • GELS AND OINTMENTS
        • Table Fig.26 Gels and Ointments Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • CAPSULES AND TABLETS
        • Table Fig.27 Capsule and Tablets Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Dry Eye Syndrome Distribution Channel Outlook
    • Table Fig.28 Dry Eye Syndrome by Distribution Channel - Market Overview ($Mn)
    • Table Fig.29 Dry Eye Syndrome by Distribution Channel Share - 2021 & 2027 (%)
    • Table Dry Eye Syndrome by Distribution Channel, 2020-2027 ($Mn)
    • HOSPITAL PHARMACY
      • Table Fig.30 Hospital Pharmacy -Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • RETAIL PHARMACY
        • Table Fig.31 Retail Pharmacy Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • ONLINE PHARMACY
        • Table Fig.32 Online Pharmacy Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Dry Eye Syndrome by Regional Outlook
    • Dry Eye Syndrome - Regional Deep Dive
      • Table Fig.33 Dry Eye Syndrome by Region- Market Overview ($Mn)
      • Table Fig.34 Dry Eye Syndrome by Region Share - 2021 & 2027 (%)
      • Table Dry Eye Syndrome by Region, 2020-2027 ($Mn)
      • NORTH AMERICA
        • Table Fig.35 North America Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
        • Table North America Dry Eye Syndrome by Country, 2020-2027 ($Mn)
      • EUROPE
        • Table Fig.36 Europe Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
        • Table Europe Dry Eye Syndrome by Country, 2020-2027 ($Mn)
      • ASIA-PACIFIC
        • Table Fig.37 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
        • Table Asia-Pacific Dry Eye Syndrome by Country, 2020-2027 ($Mn)
      • ROW
        • Table Fig.38 ROW Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Trends, Drivers, and Challenges
    • Dry Eye Syndrome - Market Trends
      • INCREASING PUBLIC-PRIVATE INITIATIVES LEADING TO EARLY DIAGNOSIS AND TREATMENT OF DRY EYE SYNDROME
      • GROWING PREVALENCE OF DRY EYE SYNDROME
    • Dry Eye Syndrome - Market Drivers
      • RISE IN AGEING POPULATION
      • GROWTH IN EYE CARE CENTERS TO HANDLE THE RISING BURDEN OF OPHTHALMOLOGICAL DISORDERS
      • INCREASING RESEARCH &DEVELOPMENT AND PROMISING PIPELINE PRODUCTS
    • Dry Eye Syndrome - Market Challenges
      • HIGH COST OF SPECIALTY DRY EYE PRODUCTS
      • ALTERNATIVE THERAPIES
    • Dry Eye Syndrome - Market Opportunities
      • DEMAND FOR THERAPIES WITH ENHANCED DELIVERY SYSTEMS
      • CREATING APPROPRIATE CLINICAL TRIAL DESIGN
  • Current and Future Players
    • Allergan
      • Table Fig.39 Allergan's Dry Eye Syndrome Portfolio Assessment
    • Aldeyra Therapeutics
      • Table Fig.40 Allergan's Dry Eye Syndrome Portfolio Assessment
    • Aurinia Pharmaceuticals
      • Table Fig.41 Aurinia's Dry Eye Syndrome Portfolio Assessment
    • Kala Pharmaceuticals
      • Table Fig.42 Kala's Dry Eye Syndrome Portfolio Assessment
    • Mitotech
      • Table Fig.43 Mitotech's Dry Eye Syndrome Portfolio Assessment
    • Novartis
      • Table Fig.44 Novartis Dry Eye Syndrome Portfolio Assessment
    • RegeneRX Biopharmaceuticals/ReGenTree
      • Table Fig.45 Novartis Dry Eye Syndrome Portfolio Assessment
    • Sun Pharmaceutical
      • Table Fig.46 Sun's Dry Eye Syndrome Portfolio Assessment
  • Competitive Landscape
    • HEAT MAP ANALYSIS
      • KEY PLAYERS STRATEGY OUTLOOK
      • RECENT PRODUCT LAUNCHES & APPROVALS
      • RECENT PARTNERSHIPS, ALLIANCES, COLLABORATIONS
  • Dry Eye Syndrome Market Vendor Snapshot
    • COMPANY SNAPSHOT: NOVARTIS AG
      • COMPANY SNAPSHOT: ABBVIE INC.
      • COMPANY SNAPSHOT: SUN PHARMACEUTICAL INDUSTRIES LTD.
      • COMPANY SNAPSHOT: JOHNSON & JOHNSON SERVICES INC.
      • COMPANY SNAPSHOT: REGENERX BIOPHARMACEUTICALS INC.
      • COMPANY SNAPSHOT: BAUSCH HEALTH COMPANIES INC.
      • COMPANY SNAPSHOT: SANTEN PHARMACEUTICAL CO. LTD.
      • COMPANY SNAPSHOT: AFT PHARMACEUTICALS PTY LTD.
      • COMPANY SNAPSHOT: VIATRIS INC.
      • COMPANY SNAPSHOT: ALCON INC.
      • OTHER MAJOR PARTICIPANTS IN THE DRY EYE SYNDROME MARKET INCLUDE THE FOLLOWING
  • Appendix
    • Methodology
    • About US
  • Contact Us

$3,950
$5,950
$7,950

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings